邹继纯, 黄量. 中药青黛中几种微量成分的研究——Ⅰ.吲哚并2,1b喹唑啉-6,12-二酮和青黛酮的分离、结构鉴定及合成J. 药学学报, 1985, 20(1): 44-51.
引用本文: 邹继纯, 黄量. 中药青黛中几种微量成分的研究——Ⅰ.吲哚并2,1b喹唑啉-6,12-二酮和青黛酮的分离、结构鉴定及合成J. 药学学报, 1985, 20(1): 44-51.
ZOU Ji-Chun, HUANG Liang. MINOR CONSTITUENTS OF QING DAI,A TRADITIONAL CHINESE MEDICINE Ⅰ.ISOLATION, STRUCTURAL DETERMINATION AND SYNTHESIS OF TRYPTANTHRIN AND QINGDAINONEJ. Acta Pharmaceutica Sinica, 1985, 20(1): 44-51.
Citation: ZOU Ji-Chun, HUANG Liang. MINOR CONSTITUENTS OF QING DAI,A TRADITIONAL CHINESE MEDICINE Ⅰ.ISOLATION, STRUCTURAL DETERMINATION AND SYNTHESIS OF TRYPTANTHRIN AND QINGDAINONEJ. Acta Pharmaceutica Sinica, 1985, 20(1): 44-51.

中药青黛中几种微量成分的研究——Ⅰ.吲哚并2,1b喹唑啉-6,12-二酮和青黛酮的分离、结构鉴定及合成

MINOR CONSTITUENTS OF QING DAI,A TRADITIONAL CHINESE MEDICINE Ⅰ.ISOLATION, STRUCTURAL DETERMINATION AND SYNTHESIS OF TRYPTANTHRIN AND QINGDAINONE

  • 摘要: 从青黛的亲脂部分除去两个主要成分靛兰(Ⅰ)及靛玉红(Ⅱ)后,分得8个微量成分(Ⅲ~Ⅹ,含量3.3×10-5~4.2×10-4%)。经物理常数的测定、光谱分析及化学合成鉴定了成分Ⅲ为吲哚并2,1 b喹唑啉-6,12-二酮(tryptanthrin)、成分Ⅳ的结构为6-吲羟-吲哚并2,1b喹唑啉酮-12。Ⅳ是首次从天然物中分离出来和确定结构的,命名为青黛酮(qingdainone)。成分Ⅴ~Ⅹ的结构尚在证实中。经初步筛选,发现Ⅲ及Ⅳ均对黑色素瘤B16有抑制作用,Ⅳ对小鼠Lewis肺癌有抑制作用。

     

    Abstract: The study of Qing Dai, a traditional Chinese medicine, has resulted in the isolation of eight minor constituents Ⅲ~Ⅹ(3.3×10-5~,4.2×10-4%) after removing of the two major constituents Ⅰ (indigotin) and Ⅱ (indirubin). Constituent Ⅲ (C15H8 N2O2) was found to be identical to the known compound indolo -2,1b-quinazoline6,12-dione (tryptanthrin). Constituent Ⅳ (C23H13N3O2) was assigned on the basis of spectrometric data to have structure Ⅳ and confirmed by condensation of Ⅲ with diacetylindoxyl. It was first found from plant origin and designated qingdainone. Ⅲ and Ⅳ were synthesized and found to be both active in test on melanoma B16 and Ⅳ also showed inhibitory action against Lewis lung carcinoma in mice.Structure determination of constituents Ⅴ~Ⅹ is in progress.

     

/

返回文章
返回